Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 27 May 2025

Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS production

in Pharmacology of Anti-Cancer Drugs

Cheng Chen
Chenying Shu
Dan Shen
Zhaowei Yan
Zeyi Liu
Jian-An Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555802

774 views

Review

Published on 23 May 2025

Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research

in Pharmacology of Anti-Cancer Drugs

Russell Moreland
Abigail Arredondo
Anupam Dhasmana
Swati Dhasmana
Shabia Shabir
Asfia Siddiqua
Bonny Banerjee
Murali M. Yallapu
Stephen W. Behrman
Subhash C. Chauhan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1543112

1,355 views

Original Research

Published on 23 May 2025

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma

in Pharmacology of Anti-Cancer Drugs

Lin Shi
Dongqi Yuan
Fuyi Zhu
Yuchao He
Ran Zuo
Liwei Chen
Yi Luo
Yu Wang
Dingzhi Huang
Peng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577232

1,522 views

Original Research

Published on 22 May 2025

Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Xueqing Zou
Yongmei Wang
Mingyuan Luan
Yizheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1605162

1,502 views

Case Report

Published on 21 May 2025

Perforation of the descending colon induced by alectinib in a patient with non-small cell lung cancer: a Case Report

in Pharmacology of Anti-Cancer Drugs

Yun Li
Ping Yu
Ran Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545614

742 views

Review

Published on 20 May 2025

Selinexor in acute myeloid leukemia: therapeutic applications and current challenges

in Pharmacology of Anti-Cancer Drugs

Ziyu Qie
Li Ma
Jie Tan
Xiaochun Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602911

1,145 views

Systematic Review

Published on 19 May 2025

The efficacy and safety of Tisotumab vedotin in the treatment of recurrent/metastatic cervical cancer: a systematic review and meta-analysis of single-arm studies

in Pharmacology of Anti-Cancer Drugs

Siyuan Zeng
Xin Li
Simin Xiao
Peina Yang
Changsheng Lin
Huiling Chen
Hu Zhao
Jun Zhan
Xue Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538980

1,354 views

Review

Published on 19 May 2025

A review on anti-cancer properties of quercetin in gastric cancer

in Pharmacology of Anti-Cancer Drugs

Xiaoxia Xie
Yan Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563229

1,715 views

Original Research

Published on 19 May 2025

Knowledge, attitudes, and practices of healthcare providers toward ADR reporting regarding thiopurine drugs for the treatment of acute lymphoblastic leukemia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

in Pharmacology of Anti-Cancer Drugs

Eyuel Kassa
Mastewal Birhan
Mulugeta Ayalew
Aschalew Gelaw
Abdulkader Mohamedsaid Gidey
Degalem Tilahun Worku
Awole Mekonen
Ermias Teklehaimanot
Assefa Asnakew
Alazar Amare

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1486415

986 views

Systematic Review

Published on 16 May 2025

Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors combined with chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Jiaojiao Yu
Zhijing Wang
Mingxu Li
Hua Zhu
Xiaoxia Tang
Ke Luan
Yinhuan Zhi
Shan Yin
Yuanqi Su
Jingyan Long

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570467

1,357 views

Original Research

Published on 15 May 2025

Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway

in Pharmacology of Anti-Cancer Drugs

Zhiyong Du
Cuiping Sun
Jiawei Wu
Hongwei Gao
Jialong Wu
You Zhou
Xuechao Wu
Liping Shen
Qing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546285

1,124 views

Original Research

Published on 15 May 2025

IL6/CCL2 from M2-polarized microglia promotes breast cancer brain metastasis and the reversal effect of β-elemene

in Pharmacology of Anti-Cancer Drugs

Qian Feng
Cai-Zhi Li
Yi-Hua Zou
Xue-Yu Wang
Xia Yang
Rong Zhang
Zhong-Qiu Liu
Rong-Rong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547333

1,325 views

Case Report

Published on 15 May 2025

Successful treatment of an elderly patient with relapsed/refractory angioimmunoblastic T-cell lymphoma with the PI3Kδ inhibitor linperlisib: a Case Report

in Pharmacology of Anti-Cancer Drugs

Ming-Qiang Chu
Ting-Juan Zhang
Qian Yang
Yuan Feng
Chao Lu
Yong-Hui Ji
Jun Qian
Jing-Dong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554501

964 views

Review

Published on 15 May 2025

Tumor-derived exosomes as promising tools for cancer diagnosis and therapy

in Pharmacology of Anti-Cancer Drugs

Xirui Wang
Yanfang Liu
Yaowen Jiang
Qinghua Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596217

1,133 views

Review

Published on 15 May 2025

Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications

in Pharmacology of Anti-Cancer Drugs

Si-Fu Yang
Xiao-Chen Chen
Yao-Jie Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598009

1,218 views

Review

Published on 15 May 2025

Autophagy as a potential therapeutic target in regulating improper cellular proliferation

in Pharmacology of Anti-Cancer Drugs

Prashant Kumar
Akash Choudhary
Sumit Kinger
Yuvraj Anandrao Jagtap
Vijay Kumar Prajapati
Deepak Chitkara
Subashchandrabose Chinnathambi
Rahul Kumar Verma
Amit Mishra

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579183

1,608 views